News

Bharat Biotech to lead phase 3 trials of promising Shigella vaccine
Bharat Biotech has partnered with GSK to advance the Shigella vaccine altSonflex1-2-3. With strong early trial results and no ...
Bharat Biotech to advance development of GSK's Shigella vaccine candidate for severe bacterial diarrhoea
The altSonflex1-2-3 vaccine candidate, developed by GSK and now advancing through a strategic collaboration with Bharat Biotech, represents one of the most advanced Shigella vaccine candidates ...
Bharat Biotech partners with GSK to develop a next-generation Shigella vaccine candidate
Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing, announced on Thursday that it has partnered with GSK plc, a global biopharma company, for the ...
GSK Licenses Shigella Vaccine Candidate to Bharat Biotech
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
From AI to aerospace: Europe’s most innovative companies shaping tomorrow
For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the ...